1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
(
- Contribution to journal › Article
-
Mark
Targeting miRNA by CRISPR/Cas in cancer : advantages and challenges
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Testicular Dysfunction Among Cancer Survivors
(
- Contribution to journal › Scientific review
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors
(
- Contribution to journal › Article
- 2018
-
Mark
The role of phosphatidylinositol 4-phosphate 5-kinase type І alpha (PIP5K1α) and utility of its inhibitor for targeting metastatic cancer
(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Cellular targets of HAMLET, their role in tumor cell death and therapeutic potential
2016)(
- Thesis › Doctoral thesis (compilation)
- 2013
-
Mark
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
(
- Contribution to journal › Article
- 2007
-
Mark
In the shadow of bad news - views of patients with acute leukaemia, myeloma or lung cancer about information, from diagnosis to cure or death
(
- Contribution to journal › Article
-
Mark
Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations
(
- Contribution to journal › Article